(1 - 11 von 15
)
Neuralstem Chief Scientific Officer To Present At Spinal Cord Injury...
www.finanznachrichten.de
ROCKVILLE, Md., April 25, PRNewswire/ --Neuralstem, Inc. (NYSE Amex: CUR) announced that Karl Johe, PhD, Chairman and Chief Scientific Officer, will present at ...
One moment, please...
www.disabled-world.com
Karl Johe, PhD, Neuralstem's Chairman and Chief Scientific Officer, explained the scientific rationale behind the Neuralstem therapy.
Next events - German Biotech Database
www.germanbiotech.com
... in Phase I, which was through direct injections into the gray matter of the spinal cord," said Karl Johe, PhD, Neuralstem Chairman and Chief Scientific Officer.
Neuralstem Announces Publication of a Study Showing
www.globenewswire.com
... deficits across three different indications—stroke, spinal cord injury, and ALS,” said Karl Johe, PhD, Chief Scientific Officer at Neuralstem.
sortiert nach Relevanz / Datum